Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 691 AL 705

Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer's disease comorbidities?

Davidson M, Stanciu GD, Rabinowitz J, Untu I, Dobrin RP, Tamba BI.

Dialogues Clin Neurosci. 2025 Dec;27(1):1-12. doi: 10.1080/19585969.2025.2480566. Epub 2025 Mar 19.

Association between comorbidity indices and nursing home admission in patients with Alzheimer's disease: a longitudinal observational study using the MEMORA cohort

Temedda MN, Garnier-Crussard A, Moutet C, Mouchoux C, Dauphinot V.

BMC Geriatr. 2025 Apr 16;25(1):254. doi: 10.1186/s12877-025-05898-6.

Feasibility and acceptability of a telephone-based ACT intervention for caregivers (TACTICs) of adults with Alzheimer's disease and related dementias (ADRD): a randomized pilot during the COVID-19 pandemic

Hockemeyer NG, Johns SA, Judge KS, Baucco C, Gowan T, Slaven JE, Fowler NR.

Aging Ment Health. 2025 Apr;29(4):639-650. doi: 10.1080/13607863.2025.2453823. Epub 2025 Jan 21.

The effects of transcranial direct current stimulation on global cognition in patients with Alzheimer's disease: An update meta-analysis

Su S, Huang R, Liu Y.

J Alzheimers Dis. 2025 Jan;103(1):19-37. doi: 10.1177/13872877241298303. Epub 2025 Jan 9.

Virtual reality interventions and their effects on the cognition of individuals with Alzheimer's disease: A systematic review and meta-analysis

Santos VD, Costa AC, Junior NC, Delaere FJ, Serlet S, Dourado MCN.

J Alzheimers Dis. 2025 Jan;103(1):68-80. doi: 10.1177/13872877241299037. Epub 2024 Nov 25.

Conventional and Emerging Drug Targeting Sites in Alzheimer's Disease and the Role of Translational Informatics in its Diagnosis and Management

Khan KA, Esa M, Kamal Z, Ullah B, Perry G, Kamal S, Ahmad S, Hussain H, Ullah A, Shafique M.

Curr Neuropharmacol. 2025;23(14):1894-1917. doi: 10.2174/011570159X361867250313073624.

The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease

Maki Y, Ubuka T, Yamane Y.

J Alzheimers Dis. 2025 Jan;103(2):358-360. doi: 10.1177/13872877241301806. Epub 2024 Dec 5.

Recent Advances in the Application of Artificial Intelligence in Alzheimer's Disease

Yao L, Ni J, Wei M, Li T, Li F, Wang T, Xiao W, Shi J, Tian J.

Curr Alzheimer Res. 2025;22(11):815-827. doi: 10.2174/0115672050410489250930175402.

Twelve weeks of exercise training improves cognitive status, physical performance and quality of life in Alzheimer's disease: A systematic review and meta-analysis

de Sá Leitão CVF, Moraes BF, Leite GAPD, Duarte AG, da Silva MVG, de Oliveira GM, Andrade FAB, da Silva JAB, Dos Santos RCC, Figueiredo GS, Campos HO, Leite LHR, Drummond LR, Coimbra CC.

Ageing Res Rev. 2025 Feb;104:102655. doi: 10.1016/j.arr.2025.102655. Epub 2025 Jan 10.

PDE4D inhibitors: Opening a new era of PET diagnostics for Alzheimer's disease

Shi L, Wang X, Si H, Song W.

Neurochem Int. 2025 Jan;182:105903. doi: 10.1016/j.neuint.2024.105903. Epub 2024 Dec 6.

Effect of Social Restriction Due to the COVID-19 Pandemic on Activity of Daily Living and Disease Severity of Patients With Alzheimer Disease: Sub-analysis of a Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets

Nakamura Y, Omori T, Nishiyama K, Ishikawa I, Aoki H, Nagakura N.

Alzheimer Dis Assoc Disord. 2025 Jan-Mar 01;39(1):44-50. doi: 10.1097/WAD.0000000000000657. Epub 2025 Jan 31.

Anti-Amyloid Therapies for Alzheimer's Disease and Amyloid-Related Imaging Abnormalities: Implications for the Emergency Medicine Clinician

Rech MA, Carpenter CR, Aggarwal NT, Hwang U.

Ann Emerg Med. 2025 Jun;85(6):526-536. doi: 10.1016/j.annemergmed.2024.12.002. Epub 2025 Jan 17.

Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD)

Boada M, Neve A, Das B, Wojtowicz J, Huang Z, Bullain S, Watkin M, Lott D, Bittner T, Delmar P, Klein G, Hofmann C, Kerchner GA, Smith J, Baudler M, Fontoura P, Doody RS.

J Alzheimers Dis. 2025 Jan;103(2):528-541. doi: 10.1177/13872877241303644. Epub 2024 Dec 16.

A thematic review on therapeutic toys and games for the elderly with Alzheimer's disease

You D, Hasley Bin Ramli S, Ibrahim R, Hibatullah Bin Romli M, Li Z, Chu Q, Yu X.

Disabil Rehabil Assist Technol. 2025 Jan;20(1):1-13. doi: 10.1080/17483107.2023.2299713. Epub 2024 Feb 1.

Molecular Modeling Insights on the Pharmaceuticals and Hypotheses of Alzheimer's Disease

de Castro AA, Silva HF, Garcia MVFP, Homem-de-Mello P, Ramalho TC.

Curr Med Chem. 2025;32(25):5110-5138. doi: 10.2174/0109298673318143240823064403.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias